Daiken Medical Co., Ltd. (TYO:7775)
Japan · Delayed Price · Currency is JPY 428.00
0.00 (0.00%)
Aug 25, 2026, 3:30 PM JST
Daiken Medical Revenue
Daiken Medical had revenue of 2.44B JPY in the quarter ending June 30, 2026, a decrease of -2.34%. This brings the company's revenue in the last twelve months to 10.23B, up 1.77% year-over-year. In the fiscal year ending March 31, 2026, Daiken Medical had annual revenue of 10.29B with 3.41% growth.
Revenue (ttm)
10.23B
Revenue Growth
+1.77%
P/S Ratio
1.20
Revenue / Employee
55.31M
Employees
185
Market Cap
12.30B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 10.29B | 339.00M | 3.41% |
| Mar 31, 2025 | 9.95B | 201.00M | 2.06% |
| Mar 31, 2024 | 9.75B | 613.00M | 6.71% |
| Mar 31, 2023 | 9.14B | 597.00M | 6.99% |
| Mar 31, 2022 | 8.54B | 679.00M | 8.64% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| JMS Co.,Ltd. | 65.43B |
| Shofu | 41.28B |
| SEED Co.,Ltd. | 34.24B |
| Medikit | 24.26B |
| Japan Eyewear Holdings | 19.30B |
| Shigematsu Works | 15.95B |
| Kitazato | 11.53B |
| Platz | 8.29B |
Daiken Medical News
- 7 months ago - Elastomeric Infusion Pumps Market worth $1.49 billion by 2030 at 5.3%, says MarketsandMarkets™ - Benzinga
- 9 months ago - Elastomeric Infusion Pumps Market worth $1.49 billion by 2030, at a CAGR of 5.3%, says MarketsandMarkets™ - Benzinga